CHRD team are first in the world to implant new injectable loop recorder

Prof Prash Sanders and the CHRD team implant the first percutaneous injectable loop recorder (Reveal LINQ). This technology opens the door to identifying episodes of AF to allow early anticoagulation and stroke prevention. In addition, it extends the existing capabilities of investigation of palpitations and syncope. Well done Vanessa Maxwell and Jonathon Foote from our clinical trials team and Medtronic Clinical Trials Staff for enabling this to be the first world-wide implant. Read the coverage by ABC News at: http://www.abc.net.au/news/2013-09-27/tiny-heart-monitor-implanted-by-australian-surgeons/4984882